- U.S. strikes on Iran raised doubts about Trump’s planned visit to China.
- Prediction markets showed increased bets on a greater likelihood of a delayed Trump trip.
- Analysts said trade talks may outweigh geopolitical tensions for both sides.
Check out the companies making the biggest moves premarket: AstraZeneca — The pharma giant rose 3% after its experimental drug, tozorakimab, was found to meaningfully reduce flare-ups in cases of chronic obstructive pulmonary disease. The drug delivered the results in two late-stage trials, and the company said full results will be delivered at an upcoming […]
Read More